Clinical Trials Browser

Anatomic Stage II Breast Cancer AJCC v8 × Fluorodeoxyglucose F18 × 90 days × Clear all

NCT05710328 2026-03-02

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

Phase 2 Active not recruiting

Anatomic Stage II Breast Cancer AJCC v8